Enoxaparin thromboprophylaxis in gastric bypass patients: extended duration, dose stratification, and antifactor Xa activity
- 31 October 2008
- journal article
- research article
- Published by Elsevier BV in Surgery for Obesity and Related Diseases
- Vol. 4 (5), 625-631
- https://doi.org/10.1016/j.soard.2007.11.010
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Pulmonary Embolism Complicating Bariatric Surgery: Detailed Analysis of a Single Institution’s 24-Year ExperienceJournal of the American College of Surgeons, 2006
- Predictive factors of thromboembolic events in patients undergoing Roux-en-Y gastric bypassSurgery for Obesity and Related Diseases, 2006
- Clinical pulmonary embolus after gastric bypass surgerySurgery for Obesity and Related Diseases, 2006
- Enoxaparin for Thromboprophylaxis in Morbidly Obese Patients Undergoing Bariatric Surgery: Findings of the Prophylaxis Against VTE Outcomes in Bariatric Surgery Patients Receiving Enoxaparin (PROBE) StudyObesity Surgery, 2005
- Prospective analysis of the incidence of deep venous thrombosis in bariatric surgery patientsSurgery, 2005
- Bleeding after laparoscopic gastric bypass: Case report and literature reviewSurgery for Obesity and Related Diseases, 2005
- Enoxaparin effect depends on body-weight and current doses may be inadequate in obese patientsBritish Journal of Surgery, 2003
- Duration of Prophylaxis against Venous Thromboembolism with Enoxaparin after Surgery for CancerThe New England Journal of Medicine, 2002
- A Comparison of Two Different Prophylactic Dose Regimens of Low Molecular Weight Heparin in Bariatric SurgeryObesity Surgery, 2002
- GASTRIC BYPASSSurgical Clinics of North America, 2001